Probetex White Paper
& Press Releases
Probetex, Inc. is Awarded an STTR Phase I Grant from the National
Institutes of Health.
Probetex was awarded a one-year $149,000
grant to develop and test differentiation potential of three established
embryonic kidney cell lines including rat and mouse metanephric mesenchymal and rat ureteric bud
cells. The embryonic stem cells will be
tested for pluripotency to differentiate into adult kidney
structures. More…
Probetex, Inc. is Awarded an SBIR Phase II Grant from the National
Institutes of Health.
Probetex was awarded a two-year $688,000
grant to continue its program to develop tissue products from renal
disease. The company will develop
products for commercialization to aid researchers in investigating kidney
disease. Products include tissue sections for histopathological
analysis, tissue lysates, and isolated RNA for
molecular biological assessment of a variety of experimental models of kidney
disease. The models include immune-mediated glomerulonephritis,
mesangioproliferative GN, diabetic nephropathy, lupus nephritis, renal fibrosis,
and acute renal failure. In addition, the company will establish a cell bank to
commercialize a variety of kidney cell lines including glomerular mesangial,
epithelial, and endothelial cells and renal fibroblasts. More…
Probetex is featured
on a local San Antonio television news station- KSAT
Medical news reporter Angela Vierville
reports on a local laboratory describing how the company is aiding kidney
researchers around the world. Clip…
Rise in Kidney Failure Could Tax State Coffers
San Antonio Business Journal
Scott Bailey
Rise in End-Stage Renal Disease (ESRD) is challenging state and federal health care programs. The article discusses the growing number of ESRD patients, the national costs of patient treatment , and availability of funds to treat this debilitating disease. Probetex is featured as a local biotechnology company with a mission to facilitate researchers in their quest to combat kidney disease by providing resources that are not readily available in their own laboratories. Also highlighted is Probetex's recent partnering with the University of Texas Health Science Center, San Antonio to license and develop a mouse, rat and human kidney cell lines.
Probetex licenses kidney cells for commercialization.
Probetex finalized agreements with the University of Texas Health Science Center to license 7 kidney cell lines. The cells include human and rat glomerular mesangial cells, bovine glomerular endothelial cells and rodent embryonic kidney stem cells. More....
October 27-November 1, 2004
Probetex to Attend Renal Week-2004.
Probetex, Inc., will attend the American Society of Nephrology’s annual meeting in St. Louis, Mo. October 27-November 1, 2004. Curagen Corporation (New Branford, CT) in collaboration with Probetex will present a poster featuring gene expression analysis data derived from the anti-thy 1 model of mesangioproliferative glomerulonephritis. More……
Probetex Graduates from Small Business Incubator-Moves Research Facility.
Probetex, Inc., a TEKSA Innovations Corp. Portfolio Company, has received seed capital from the National Institutes of Health and is graduating from incubation. Probetex now intends to function as an independent company as it further grows its experimental pathology services business. The company recently moved its program to a facility closer to its affiliate institutions. About Us…
Largest S.A. Bioscience & Medical Technology Companies
San Antonio Business Journal
This listing of the largest bioscience and medical technology companies in San Antonio was released by the San Antonio Business Journal, with Probetex, Inc. listed as the seventh largest in terms of local research and development employees.
April , 2004
Probetex, Inc. is Awarded an SBIR Phase I grant from the National Institutes of Health.
There is a significant need and market potential for readily available reagents and tissue products from established models and human cases of renal disease. To address this deficit, Probetex was founded as a "Renal Research Resource Company" to create a repository of “off-the-shelf” tissue products from renal disease to provide readily available samples and help investigators to quickly and efficiently explore their research ideas. Start-up funds were awarded to Probetex to develop tissue products from three models of renal disease. More……
A Shelter from the Storm
San Antonio Express News
BusinessExpress
Small-business incubators protect start-ups from market forces and overhead until they can stand on their own. Probetex is featured as a TEKSA Innovations Corp small-business startup in an article about the merits of Business Incubators.
Probetex to Attend Renal Week-2003.
Probetex, Inc., will attend the American Society of
Nephrology’s annual meeting in Philadelphia November 12-17. Baxter Healthcare
Corporation, Nephrology Division (McGaw Park, IL) in
collaboration with Probetex will present data on “Combined Renoprotective
Effect of Captopril and Pravastatin
in
Probetex participates with TEKSA Innovations, Our Lady of the Lake University with National Science Foundation Grant for Disadvantaged Students.
This summer, an innovative program in San Antonio is teaching economically disadvantaged high school students to learn web site design and development while giving college students an opportunity to manage a team. The end product of their collaboration will provide local small businesses with web sites. More…